ArticleOPEN ACCESS

Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD

American Journal of Kidney Diseases
DOI: 10.1053/j.ajkd.2024.06.005
0Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Stamp, L. K., Dalbeth, N., & Mount, D. B. (2024, November 1). Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD. American Journal of Kidney Diseases. W.B. Saunders. https://doi.org/10.1053/j.ajkd.2024.06.005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free